Sessions are scheduled in local time (CEST)

Displaying One Session

Frankfurt Hall Industry Satellite Symposium
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Room
Frankfurt Hall
Chairs
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

Welcome and introduction (ID 6)

Lecture Time
18:30 - 18:35
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Authors
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

Are we taking the right choices? New insights on risk assessment in patients with HER2+ EBC (ID 7)

Lecture Time
18:35 - 18:45
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Christian Jackisch (Offenbach am Main, Germany)
Authors
  • Christian Jackisch (Offenbach am Main, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

The wise move: Current strategies in high-risk HER2+ EBC (ID 8)

Lecture Time
18:45 - 18:55
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Miguel Martin (Madrid, Spain)
Authors
  • Miguel Martin (Madrid, Spain)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

From data to practice: A clinical case challenge (ID 9)

Lecture Time
18:55 - 19:10
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Christian Jackisch (Offenbach am Main, Germany)
Authors
  • Christian Jackisch (Offenbach am Main, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

Delivering the continuum of care: Setting each patient up for treatment success (ID 10)

Lecture Time
19:10 - 19:25
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Authors
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer

Q&A and closing remarks (ID 11)

Lecture Time
19:25 - 19:30
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Luftner (Brandenburg an der Havel, Germany)
Authors
  • Diana I. Luftner (Brandenburg an der Havel, Germany)